ST
JAZZ icon

Spot Trading’s Jazz Pharmaceuticals JAZZ Stock Holding History

Spot Trading’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		$819K Buy
5,600
+5,400
+2,700% +$817K 0.01% 1304
2017
Q2 		$31K Buy
+200
New +$30.6K ﹤0.01% 2935
2017
Q1 		– Sell
-2,300
Closed -$251K – 3127
2016
Q4 		$251K Buy
+2,300
New +$256K 0.01% 1793
2016
Q1 		– Sell
-12,800
Closed -$1.8M – 3703
2015
Q4 		$1.8M Buy
12,800
+5,300
+71% +$734K 0.02% 1093
2015
Q3 		$996K Buy
+7,500
New +$1.29M 0.01% 1575
2015
Q1 		– Sell
-2,000
Closed -$327K – 4105
2014
Q4 		$327K Sell
2,000
-700
-26% -$116K ﹤0.01% 2639
2014
Q3 		$434K Sell
2,700
-1,700
-39% -$261K ﹤0.01% 2654
2014
Q2 		$647K Buy
4,400
+1,900
+76% +$264K ﹤0.01% 2487
2014
Q1 		$347K Buy
2,500
+2,400
+2,400% +$361K ﹤0.01% 2815
2013
Q4 		$13K Sell
100
-5,100
-98% -$528K ﹤0.01% 3730
2013
Q3 		$478K Buy
5,200
+400
+8% +$32.3K ﹤0.01% 2461
2013
Q2 		$330K Buy
+4,800
New +$293K ﹤0.01% 2719

Other funds holding JAZZ

PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
SIG
Senator Investment Group New York $2.18B AUM 58.56% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Spot Trading's JAZZ Position: Q3 2017 in Review

Spot Trading opened a new position in Jazz Pharmaceuticals (JAZZ) in Q3 2017: 2,113 shares worth $309K. The stake represents 0.01% of the portfolio and ranks #1963 among its holdings. This is a return to the name: Spot Trading previously reported a position in JAZZ as recently as Q4 2016.

Spot Trading first reported a position in JAZZ in Q2 2013 and has held it in 9 quarters since. The position peaked at $700K in Q3 2015. 303 funds tracked by Wall St. Rank hold JAZZ as of Q3 2017.

  • Spot Trading held 2,113 shares of Jazz Pharmaceuticals worth $309K as of Q3 2017.
  • Jazz Pharmaceuticals was a new Spot Trading position in Q3 2017.
  • Jazz Pharmaceuticals made up 0.01% of Spot Trading's portfolio in Q3 2017, its #1963 holding.
  • Spot Trading first reported a position in Jazz Pharmaceuticals in Q2 2013 and has held it in 9 quarters since.
  • Spot Trading's Jazz Pharmaceuticals position peaked at $700K in Q3 2015.
  • 303 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q3 2017.

Based on Spot Trading's 13F filing for Q3 2017, filed 6 Nov 2017.